Medicaid Fraud Defense for Hospice Businesses

Strategic Legal Protection for Hospice Owners, Investors, and Administrators

Operating a hospice business today means managing far more than patient care. Owners, administrators, and investors in hospice organizations face a distinct set of legal exposures tied to how the business itself is structured, financed, bought, sold, and expanded. A Medicaid fraud investigation not only threatens clinical staff and billing departments. It threatens ownership, equity value, and the ability to continue operating at all.

At The Criminal Defense Firm, we represent hospice business owners, private equity groups, multi-site operators, and administrators facing federal and state scrutiny tied to Medicaid participation. Our Medicaid fraud defense team includes former federal prosecutors who understand how the government builds cases against hospice organizations, from the standpoint of business structure and ownership liability, not just clinical documentation.

Why Hospice Businesses Face Unique Regulatory Risk

Hospice is one of the most heavily Medicaid-dependent sectors in healthcare, and it has also become one of the fastest-consolidating. Private equity acquisitions, multi-state expansion, and rapid changes of ownership have drawn direct attention from the: 

• Department of Justice (DOJ)
• Department of Health and Human Services Office of Inspector General (HHS-OIG)
• State Medicaid Fraud Control Units (MFCUs)

Investigators increasingly look not only at individual clinical decisions but at the business arrangements surrounding those decisions, including how a hospice was acquired, financed, and integrated into a larger organization.

For hospice owners and administrators, this means liability can arise from decisions made well before an alleged billing error ever occurred. A financing arrangement negotiated years earlier, a management agreement inherited through acquisition, or a referral relationship established under prior ownership can all become the focus of a current investigation, regardless of who was running the business at the time the arrangement was made.

Successor Liability in Mergers and Acquisitions

When a hospice agency is acquired, the buyer does not automatically leave behind the seller’s regulatory history. Under the doctrine of successor liability, an acquiring entity can inherit exposure for billing practices, compliance gaps, or pending investigations tied to the business it purchased, particularly in asset purchases structured to continue substantially the same operations under new ownership.

This creates significant risk during due diligence. A buyer who fails to identify red flags in a target hospice’s billing history, referral arrangements, or compliance program may find itself defending a False Claims Act investigation for conduct that occurred before the transaction closed. 

Our attorneys assist both buyers and sellers in structuring transactions, conducting pre-acquisition compliance reviews, and negotiating indemnification provisions designed to allocate this risk appropriately.

Change of Ownership (CHOW) Compliance

Medicaid and Medicare both require formal notification and approval processes when a hospice undergoes a change of ownership. Failing to properly report a CHOW or attempting to transfer a provider agreement without required state or CMS approval can expose the business to allegations that it operated without valid Medicaid billing authority during the transition period.

These issues frequently surface during unrelated audits, when investigators discover that billing continued under a provider number that should have been reassigned, suspended, or reviewed as part of a completed sale. We work with hospice buyers and sellers to ensure CHOW filings are accurate, timely, and properly documented, reducing the risk that an otherwise routine transaction becomes the basis for a fraud allegation.

Multi-Site and Franchise Liability

Hospice organizations operating across multiple locations, whether through direct ownership, franchise arrangements, or management services agreements, face a particular risk: liability at one location can expose the entire organization. Federal investigators frequently examine whether billing irregularities at a single site reflect an isolated administrative issue or a corporate-level policy or practice.

For multi-site operators, this makes centralized compliance oversight essential. A compliance program that exists only on paper at the corporate level, without meaningful enforcement at each site, can actually increase exposure by suggesting the organization knew about risks it failed to address. We help multi-site hospice organizations build and defend compliance structures that hold up under this kind of scrutiny, and we represent parent organizations when investigations that begin at a single location threaten to expand corporate-wide.

Investor and Private Equity Exposure

Private equity firms and other investors with ownership stakes in hospice organizations face their own distinct set of risks. Depending on the level of operational control an investor exercises, the government may attempt to extend liability beyond the operating entity to the ownership group itself, particularly where investors were involved in setting billing targets, compensation structures, or growth strategies that allegedly incentivized improper claims.

Investors facing this kind of exposure need counsel who understands both the healthcare regulatory framework and the corporate governance structures common to private equity ownership. Our attorneys work directly with investment groups to assess exposure, respond to civil investigative demands, and, where appropriate, negotiate resolutions that protect the broader investment while addressing operational-level concerns.

Exclusion and Its Impact on Business Value

For a hospice business, exclusion from federal healthcare programs is often more damaging than any fine. Because Medicaid and Medicare reimbursement typically represents the overwhelming majority of hospice revenue, exclusion can effectively eliminate the business’s ability to operate, regardless of the underlying merits of the allegations.

This makes early intervention critical, not only to defend against the underlying allegations but to protect enterprise value. A pending investigation can also complicate refinancing, delay or derail a planned sale, and trigger default provisions in loan agreements tied to regulatory compliance representations. 

We work to resolve investigations as early as possible, specifically to limit this kind of collateral business damage, and we advise ownership groups on how to address a pending investigation in the context of financing, refinancing, or sale negotiations.

Building a Defensible Compliance Program at the Ownership Level

An effective compliance program for a hospice business needs to function at both the clinical and corporate levels. At the ownership and administrative level, this typically includes clear documentation of governance decisions, defined lines of authority between corporate leadership and site-level administrators, financial controls that separate billing incentives from clinical decision-making, and a documented process for escalating and resolving compliance concerns identified at any location. 

A program that demonstrates genuine oversight at the ownership level can be a powerful tool in distinguishing an isolated site-level error from evidence of a company-wide scheme.

How We Defend Hospice Businesses

Our team’s approach begins with understanding the full corporate structure of the business under investigation, including ownership, financing arrangements, and any recent transactions. From there, we conduct an internal assessment to identify the scope of potential exposure, engage directly with investigators and prosecutors to narrow the issues in play, and, where litigation becomes unavoidable, defend the business and its ownership through every stage of the process. 

We also work proactively with hospice buyers, sellers, and investors before problems arise, helping structure transactions and compliance programs that reduce risk from the outset.

Contact The Criminal Defense Firm

If your hospice business, ownership group, or investment entity is facing a Medicaid fraud investigation, a disputed acquisition liability issue, or scrutiny tied to a change of ownership, the decisions made now can determine whether the business survives the process intact. Contact us today at (866) 603-4540 for a confidential consultation with our healthcare fraud defense team.

Frequently Asked Questions

Q: Can a buyer be held liable for a hospice’s Medicaid fraud that occurred before the sale? 

Yes, depending on how the transaction was structured. Under successor liability principles, an acquiring entity that continues substantially the same operations may inherit exposure for pre-acquisition conduct, particularly in asset purchases. Proper due diligence and carefully drafted indemnification provisions can help allocate this risk before a deal closes.

Q: What happens if a change of ownership isn’t properly reported to Medicaid? 

Billing that continues under a provider number without proper CHOW approval can be treated as billing without valid authority, which may expose both the buyer and seller to civil or criminal liability. Timely and accurate CHOW filings are essential to avoid this outcome.

Q: If one location in a multi-site hospice organization is investigated, can the whole company be at risk? 

Potentially. Investigators often examine whether an issue at one site reflects a broader corporate policy or a failure of oversight at the parent level. Strong, consistently enforced compliance programs across all locations help limit this kind of expansion.

Q: Can private equity investors be personally liable for a portfolio hospice company’s Medicaid fraud? 

It depends on the investor’s level of operational involvement. Investors who play an active role in setting billing practices, compensation, or growth targets face greater exposure than passive financial investors. Each situation requires an individualized assessment of the investor’s actual role.

Q: How does a pending Medicaid fraud investigation affect the sale of a hospice business? 

An open investigation can complicate or delay a sale, reduce valuation, and trigger representations and warranties issues in a purchase agreement. Resolving or narrowing the investigation early is often critical to preserving a planned transaction.

Q: What is the difference between exclusion and a civil monetary penalty? 

A civil monetary penalty is a financial sanction. Exclusion bars the provider from billing Medicaid or Medicare altogether, which, for most hospice businesses, eliminates the majority of available revenue. Exclusion is typically the more severe and business-threatening consequence of the two.

Last Updated: 08-25-2026